# Clinical Trial of Safety and Clinical Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Children

> **NCT01843842** · PHASE3 · COMPLETED · sponsor: **Materia Medica Holding** · enrollment: 306 (actual)

## Conditions studied

- Acute Upper Respiratory Tract Infections

## Interventions

- **DRUG:** Ergoferon
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01843842
- **Lead sponsor:** Materia Medica Holding
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 306 (ACTUAL)
- **Last updated:** 2018-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01843842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01843842, "Clinical Trial of Safety and Clinical Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Children". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01843842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*